← Back to Search

Supportive Messaging for Major Depressive Disorder (STEM Trial)

N/A

Waitlist Available

Led By Vincent Agyapong, MD,PhD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6, 12 and 24 weeks

Awards & highlights

STEM Trial Summary

This trial is testing whether email messages can be an effective treatment for depression, compared to text messages.

Eligible Conditions

Depression

STEM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6, 12 and 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6, 12 and 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6, 12 and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Patient Health Questionnaire (PHQ)-9 scores

Change in the WHO (Five) Well-Being Index (WHO-5)

Secondary outcome measures

Change in the Generalized Anxiety Disorder Assessment (GAD-7) score

STEM Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Email Message GroupExperimental Treatment1 Intervention

This group will receive same supportive message as the Text Message group but through their email addresses, in addition to receiving standard care

Group II: Text Message GroupActive Control1 Intervention

This group will receive daily supportive messages through Short Messaging Service (SMS) on their mobile phones in addition to standard care

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

384,712 Total Patients Enrolled

18 Trials studying Depression

8,812 Patients Enrolled for Depression

Vincent Agyapong, MD,PhDPrincipal InvestigatorUniversity of Alberta

1 Previous Clinical Trials

1,132 Total Patients Enrolled

Media Library

Supportive messages Clinical Trial Eligibility Overview. Trial Name: NCT04638231 — N/A

Depression Research Study Groups: Text Message Group, Email Message Group

Depression Clinical Trial 2023: Supportive messages Highlights & Side Effects. Trial Name: NCT04638231 — N/A

Supportive messages 2023 Treatment Timeline for Medical Study. Trial Name: NCT04638231 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total cohort size of this experiment?

"Affirmative. According to the information hosted on clinicaltrials.gov, this study is currently searching for participants, having been posted initially on April 8th 2021 and most recently edited on April 3rd 2022. The medical trial needs to recruit a total of 100 patients from one site."

Answered by AI

Does this research project admit participants of twenty years and over?

"This clinical trial is available to adults aged 18-65. There are also 406 trials for minors and 1454 trials specifically focusing on senior citizens."

Answered by AI

Is recruitment ongoing for this research initiative?

"According to clinicaltrials.gov, this research initiative which was initially advertised on April 8th 2021 is still recruiting participants. The last update was made on 4/3/2022."

Answered by AI

Is it possible to become part of this clinical trial?

"This experiment requires 100 participants with an age range between 18 and 65 diagnosed with Major Depressive Disorder through a DSM 5 assessment. To be accepted, patients must have access to both email messages and text messages from their cellular device as well as agree to the terms outlined in the consent form."

Answered by AI